Xcout Intel
Vedanta Biosciences
Vedanta Biosciences, Inc. is headquartered in Cambridge, Massachusetts, and develops groundbreaking microbiome-derived immunotherapies and therapeutics to improve patient lives.
Subscribe to see Vedanta Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vedanta Biosciences at a glance
Vedanta Biosciences is a life sciences company headquartered in United States. It has raised at least $234.8M across the 5 funding rounds on record, 4 of them with a disclosed amount. Its most recent funding round raised $118.5M in March 2023. Xcout tracks 4 named people at Vedanta Biosciences, including Dan Couto (Chief Operating Officer). Xcout recorded 1 job posting from Vedanta Biosciences in the last 90 days.
Vedanta Biosciences leadership
- Dan CoutoChief Operating Officer
- Tamra AdamsChief Financial Officer (Consultant)
- Paul McGovernChief Medical Officer (Consultant)
- Bernat OlleFounder, Chief Executive Officer
Vedanta Biosciences funding rounds
At least $234.8M raised across the 5 rounds on record (4 with a disclosed amount). The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $118.5M | — | |
| Series D | $68.4M | 14 named | |
| SEC Form D filing | $8M | — | |
| SEC Form D filing | $39.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Vedanta Biosciences
Xcout recorded 1 job posting from Vedanta Biosciences in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Vedanta Biosciences's hiring signals →
Investors
Vedanta Biosciences competitors
A few of Vedanta Biosciences's closest competitors — see the full list of competitors and alternatives →
Senda Biosciences is a biotechnology company focused on harnessing nature to program novel medicines, headquartered in Cambridge, Massachusetts.
Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases. Their flagship therapeutic, SER-109, an oral microbiome treatment, has successfully concluded Phase III clinical trials for the management of Clostridioides difficile infection (CDI). The company's pipeline further encompasses SER-155, a synthetically cultured bacterial formulation currently undergoing Phase Ib evaluation. This candidate aims to mitigate the risk of gastrointestinal and bloodstream infections, alongside graft-versus-host disease, in vulnerable patients undergoing allogeneic hematopoietic stem cell or solid organ transplantation. Additionally, Seres Therapeutics is advancing SER-287 and SER-301, both in Phase Ib for ulcerative colitis, as well as SER-401, which targets metastatic melanoma, and SER-262, also directed at Clostridioides difficile infection. Seres maintains strategic alliances through licensing and collaboration agreements with entities such as Nestec Ltd. and Memorial Sloan Kettering Cancer Center. Established in 2010, the company previously operated as Seres Health, Inc. before adopting its current name in May 2015, and it maintains its principal offices in Cambridge, Massachusetts.
Merida Biosciences is a privately held biotechnology company headquartered in Cambridge, Massachusetts. The company launched with significant funding to develop novel scientific platforms and therapeutic pipelines.
Vesalius Therapeutics is a biotechnology company founded by Flagship Pioneering to redefine how common illnesses are treated. Headquartered in Cambridge, Massachusetts, the firm applies novel human data insights to drug discovery and therapeutic development.
Get Vedanta Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Vedanta Biosciences in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access